Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04301089Phase 2Completed
Phase 2, open-label, single-arm trial in anxiety disorder and psychological distress, sponsored by National Cancer Institute. Primary endpoints: Number of Participants Who Completed Patient-Reported Outcomes (PROs) Questionnaires, Number of Participants Compliant With Virtual Reality (VR) Headset Use and 2 more. Started Mar 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04301089.